{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:49:58Z","timestamp":1790052598256,"version":"4.0.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["R01 AG37491"],"award-info":[{"award-number":["R01 AG37491"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40478-019-0755-x","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T18:10:35Z","timestamp":1562091035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2930-8634","authenticated-orcid":false,"given":"Keith A.","family":"Josephs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Rademakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Petrucelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"755_CR1","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602\u2013611. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2006.10.093","journal-title":"Biochem Biophys Res Commun"},{"key":"755_CR2","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature05016","volume":"442","author":"M Baker","year":"2006","unstructured":"Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S et al (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442:916\u2013919. \n                    https:\/\/doi.org\/10.1038\/nature05016","journal-title":"Nature"},{"key":"755_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239\u2013259","journal-title":"Acta Neuropathol (Berl)"},{"key":"755_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/14728222.2018.1439923","volume":"22","author":"E Buratti","year":"2018","unstructured":"Buratti E (2018) TDP-43 post-translational modifications in health and disease. Expert Opin Ther Targets 22:279\u2013293. \n                    https:\/\/doi.org\/10.1080\/14728222.2018.1439923","journal-title":"Expert Opin Ther Targets"},{"key":"755_CR5","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2741\/2727","volume":"13","author":"E Buratti","year":"2008","unstructured":"Buratti E, Baralle FE (2008) Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci 13:867\u2013878","journal-title":"Front Biosci"},{"key":"755_CR6","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1093\/emboj\/20.7.1774","volume":"20","author":"E Buratti","year":"2001","unstructured":"Buratti E, Dork T, Zuccato E, Pagani F, Romano M, Baralle FE (2001) Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 20:1774\u20131784. \n                    https:\/\/doi.org\/10.1093\/emboj\/20.7.1774","journal-title":"EMBO J"},{"key":"755_CR7","doi-asserted-by":"publisher","first-page":"e90452","DOI":"10.1371\/journal.pone.0090452","volume":"9","author":"Y Carlomagno","year":"2014","unstructured":"Carlomagno Y, Zhang Y, Davis M, Lin WL, Cook C, Dunmore J, Tay W, Menkosky K, Cao X, Petrucelli L et al (2014) Casein kinase II induced polymerization of soluble TDP-43 into filaments is inhibited by heat shock proteins. PLoS One 9:e90452. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0090452","journal-title":"PLoS One"},{"key":"755_CR8","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.febslet.2015.06.009","volume":"589","author":"MX Che","year":"2015","unstructured":"Che MX, Jiang LL, Li HY, Jiang YJ, Hu HY (2015) TDP-35 sequesters TDP-43 into cytoplasmic inclusions through binding with RNA. FEBS Lett 589:1920\u20131928. \n                    https:\/\/doi.org\/10.1016\/j.febslet.2015.06.009","journal-title":"FEBS Lett"},{"key":"755_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13024-019-0310-z","volume":"14","author":"J Chew","year":"2019","unstructured":"Chew J, Cook C, Gendron TF, Jansen-West K, Del Rosso G, Daughrity LM, Castanedes-Casey M, Kurti A, Stankowski JN, Disney MD et al (2019) Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy. Mol Neurodegener 14:9. \n                    https:\/\/doi.org\/10.1186\/s13024-019-0310-z","journal-title":"Mol Neurodegener"},{"key":"755_CR10","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1126\/science.aaa9344","volume":"348","author":"J Chew","year":"2015","unstructured":"Chew J, Gendron TF, Prudencio M, Sasaguri H, Zhang YJ, Castanedes-Casey M, Lee CW, Jansen-West K, Kurti A, Murray ME et al (2015) Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science 348:1151\u20131154. \n                    https:\/\/doi.org\/10.1126\/science.aaa9344","journal-title":"Science"},{"key":"755_CR11","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41593-017-0047-3","volume":"21","author":"CC Chou","year":"2018","unstructured":"Chou CC, Zhang Y, Umoh ME, Vaughan SW, Lorenzini I, Liu F, Sayegh M, Donlin-Asp PG, Chen YH, al DDM (2018) TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS\/FTD. Nat Neurosci 21:228\u2013239. \n                    https:\/\/doi.org\/10.1038\/s41593-017-0047-3","journal-title":"Nat Neurosci"},{"key":"755_CR12","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/nature05017","volume":"442","author":"M Cruts","year":"2006","unstructured":"Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, Rademakers R, Vandenberghe R, Dermaut B, Martin JJ et al (2006) Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442:920\u2013924. \n                    https:\/\/doi.org\/10.1038\/nature05017","journal-title":"Nature"},{"key":"755_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245\u2013256. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2011.09.011","journal-title":"Neuron"},{"key":"755_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/BF00293396","volume":"88","author":"DW Dickson","year":"1994","unstructured":"Dickson DW, Davies P, Bevona C, Van Hoeven KH, Factor SM, Grober E, Aronson MK, Crystal HA (1994) Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathol 88:212\u2013221","journal-title":"Acta Neuropathol"},{"key":"755_CR15","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/j.1471-4159.2009.06211.x","volume":"110","author":"D Dormann","year":"2009","unstructured":"Dormann D, Capell A, Carlson AM, Shankaran SS, Rodde R, Neumann M, Kremmer E, Matsuwaki T, Yamanouchi K, Nishihara M et al (2009) Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin. J Neurochem 110:1082\u20131094. \n                    https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06211.x","journal-title":"J Neurochem"},{"key":"755_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/00005072-200606000-00005","volume":"65","author":"MS Forman","year":"2006","unstructured":"Forman MS, Mackenzie IR, Cairns NJ, Swanson E, Boyer PJ, Drachman DA, Jhaveri BS, Karlawish JH, Pestronk A, Smith TW et al (2006) Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neuropathol Exp Neurol 65:571\u2013581","journal-title":"J Neuropathol Exp Neurol"},{"key":"755_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ana.21425","volume":"64","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle F, Morita M et al (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64:60\u201370. \n                    https:\/\/doi.org\/10.1002\/ana.21425","journal-title":"Ann Neurol"},{"key":"755_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/NEN.0b013e31816a12a6","volume":"67","author":"KJ Hatanpaa","year":"2008","unstructured":"Hatanpaa KJ, Bigio EH, Cairns NJ, Womack KB, Weintraub S, Morris JC, Foong C, Xiao G, Hladik C, Mantanona TY et al (2008) TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a Midwest-southwest consortium for FTLD study. J Neuropathol Exp Neurol 67:271\u2013279. \n                    https:\/\/doi.org\/10.1097\/NEN.0b013e31816a12a6","journal-title":"J Neuropathol Exp Neurol"},{"key":"755_CR19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/brain\/awr354","volume":"135","author":"GY Hsiung","year":"2012","unstructured":"Hsiung GY, DeJesus-Hernandez M, Feldman HH, Sengdy P, Bouchard-Kerr P, Dwosh E, Butler R, Leung B, Fok A, Rutherford NJ et al (2012) Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain 135:709\u2013722. \n                    https:\/\/doi.org\/10.1093\/brain\/awr354","journal-title":"Brain"},{"key":"755_CR20","doi-asserted-by":"publisher","first-page":"8516","DOI":"10.1074\/jbc.M809462200","volume":"284","author":"LM Igaz","year":"2009","unstructured":"Igaz LM, Kwong LK, Chen-Plotkin A, Winton MJ, Unger TL, Xu Y, Neumann M, Trojanowski JQ, Lee VM (2009) Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 Proteinopathies. J Biol Chem 284:8516\u20138524. \n                    https:\/\/doi.org\/10.1074\/jbc.M809462200","journal-title":"J Biol Chem"},{"key":"755_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2353\/ajpath.2008.080003","volume":"173","author":"LM Igaz","year":"2008","unstructured":"Igaz LM, Kwong LK, Xu Y, Truax AC, Uryu K, Neumann M, Clark CM, Elman LB, Miller BL, Grossman M et al (2008) Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol 173:182\u2013194","journal-title":"Am J Pathol"},{"key":"755_CR22","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.febslet.2008.07.027","volume":"582","author":"Y Inukai","year":"2008","unstructured":"Inukai Y, Nonaka T, Arai T, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle FE, Akiyama H, Hisanaga S et al (2008) Abnormal phosphorylation of Ser409\/410 of TDP-43 in FTLD-U and ALS. FEBS Lett 582:2899\u20132904. \n                    https:\/\/doi.org\/10.1016\/j.febslet.2008.07.027","journal-title":"FEBS Lett"},{"key":"755_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/nen.0b013e31803020cf","volume":"66","author":"KA Josephs","year":"2007","unstructured":"Josephs KA, Ahmed Z, Katsuse O, Parisi JF, Boeve BF, Knopman DS, Petersen RC, Davies P, Duara R, Graff-Radford NR et al (2007) Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol 66:142\u2013151. \n                    https:\/\/doi.org\/10.1097\/nen.0b013e31803020cf","journal-title":"J Neuropathol Exp Neurol"},{"key":"755_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-011-0839-6","volume":"122","author":"KA Josephs","year":"2011","unstructured":"Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM, Dickson DW (2011) Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol 122:137\u2013153. \n                    https:\/\/doi.org\/10.1007\/s00401-011-0839-6","journal-title":"Acta Neuropathol"},{"key":"755_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00401-009-0547-7","volume":"118","author":"KA Josephs","year":"2009","unstructured":"Josephs KA, Stroh A, Dugger B, Dickson DW (2009) Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes. Acta Neuropathol 118:349\u2013358. \n                    https:\/\/doi.org\/10.1007\/s00401-009-0547-7","journal-title":"Acta Neuropathol"},{"issue":"Suppl 1","key":"755_CR26","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1097\/01.wad.0000183889.61421.a8","volume":"19","author":"O Katsuse","year":"2005","unstructured":"Katsuse O, Dickson DW (2005) Ubiquitin immunohistochemistry of frontotemporal lobar degeneration differentiates cases with and without motor neuron disease. Alzheimer Dis Assoc Disord 19(Suppl 1):S37\u2013S43","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"755_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00401-017-1679-9","volume":"134","author":"EB Lee","year":"2017","unstructured":"Lee EB, Porta S, Michael Baer G, Xu Y, Suh E, Kwong LK, Elman L, Grossman M, Lee VM, Irwin DJ et al (2017) Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol 134:65\u201378. \n                    https:\/\/doi.org\/10.1007\/s00401-017-1679-9","journal-title":"Acta Neuropathol"},{"key":"755_CR28","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1097\/NEN.0b013e3181baacec","volume":"68","author":"WL Lin","year":"2009","unstructured":"Lin WL, Castanedes-Casey M, Dickson DW (2009) Transactivation response DNA-binding protein 43 microvasculopathy in frontotemporal degeneration and familial Lewy body disease. J Neuropathol Exp Neurol 68:1167\u20131176. \n                    https:\/\/doi.org\/10.1097\/NEN.0b013e3181baacec","journal-title":"J Neuropathol Exp Neurol"},{"key":"755_CR29","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1093\/brain\/awl271","volume":"129","author":"IR Mackenzie","year":"2006","unstructured":"Mackenzie IR, Baker M, Pickering-Brown S, Hsiung GY, Lindholm C, Dwosh E, Gass J, Cannon A, Rademakers R, Hutton M et al (2006) The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 129:3081\u20133090. \n                    https:\/\/doi.org\/10.1093\/brain\/awl271","journal-title":"Brain"},{"key":"755_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","volume":"122","author":"IR Mackenzie","year":"2011","unstructured":"Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, Perry RH, Trojanowski JQ, Mann DM, Lee VM (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122:111\u2013113. \n                    https:\/\/doi.org\/10.1007\/s00401-011-0845-8","journal-title":"Acta Neuropathol"},{"key":"755_CR31","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.brainres.2009.07.023","volume":"1296","author":"K Moisse","year":"2009","unstructured":"Moisse K, Mepham J, Volkening K, Welch I, Hill T, Strong MJ (2009) Cytosolic TDP-43 expression following axotomy is associated with caspase 3 activation in NFL\u2212\/\u2212 mice: support for a role for TDP-43 in the physiological response to neuronal injury. Brain Res 1296:176\u2013186. \n                    https:\/\/doi.org\/10.1016\/j.brainres.2009.07.023","journal-title":"Brain Res"},{"key":"755_CR32","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/brain\/awv050","volume":"138","author":"ME Murray","year":"2015","unstructured":"Murray ME, Lowe VJ, Graff-Radford NR, Liesinger AM, Cannon A, Przybelski SA, Rawal B, Parisi JE, Petersen RC, Kantarci K et al (2015) Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum. Brain 138:1370\u20131381. \n                    https:\/\/doi.org\/10.1093\/brain\/awv050","journal-title":"Brain"},{"key":"755_CR33","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130\u2013133","journal-title":"Science"},{"key":"755_CR34","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1093\/hmg\/ddp275","volume":"18","author":"T Nonaka","year":"2009","unstructured":"Nonaka T, Kametani F, Arai T, Akiyama H, Hasegawa M (2009) Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum Mol Genet 18:3353\u20133364. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddp275","journal-title":"Hum Mol Genet"},{"key":"755_CR35","doi-asserted-by":"publisher","first-page":"18845","DOI":"10.1074\/jbc.M111.231118","volume":"286","author":"GS Pesiridis","year":"2011","unstructured":"Pesiridis GS, Tripathy K, Tanik S, Trojanowski JQ, Lee VM (2011) A \u201ctwo-hit\u201d hypothesis for inclusion formation by carboxyl-terminal fragments of TDP-43 protein linked to RNA depletion and impaired microtubule-dependent transport. J Biol Chem 286:18845\u201318855. \n                    https:\/\/doi.org\/10.1074\/jbc.M111.231118","journal-title":"J Biol Chem"},{"key":"755_CR36","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257\u2013268. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2011.09.010","journal-title":"Neuron"},{"key":"755_CR37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-011-0937-5","volume":"123","author":"H Stewart","year":"2012","unstructured":"Stewart H, Rutherford NJ, Briemberg H, Krieger C, Cashman N, Fabros M, Baker M, Fok A, DeJesus-Hernandez M, Eisen A et al (2012) Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p. Acta Neuropathol 123:409\u2013417. \n                    https:\/\/doi.org\/10.1007\/s00401-011-0937-5","journal-title":"Acta Neuropathol"},{"key":"755_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/2051-5960-1-33","volume":"1","author":"RH Tan","year":"2013","unstructured":"Tan RH, Shepherd CE, Kril JJ, McCann H, McGeachie A, McGinley C, Affleck A, Halliday GM (2013) Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43. Acta Neuropathol Commun 1:33. \n                    https:\/\/doi.org\/10.1186\/2051-5960-1-33","journal-title":"Acta Neuropathol Commun"},{"key":"755_CR39","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1093\/brain\/aws230","volume":"135","author":"H Tsuji","year":"2012","unstructured":"Tsuji H, Arai T, Kametani F, Nonaka T, Yamashita M, Suzukake M, Hosokawa M, Yoshida M, Hatsuta H, Takao M et al (2012) Molecular analysis and biochemical classification of TDP-43 proteinopathy. Brain 135:3380\u20133391. \n                    https:\/\/doi.org\/10.1093\/brain\/aws230","journal-title":"Brain"},{"key":"755_CR40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.bbrc.2011.11.066","volume":"417","author":"H Tsuji","year":"2012","unstructured":"Tsuji H, Nonaka T, Yamashita M, Masuda-Suzukake M, Kametani F, Akiyama H, Mann DM, Tamaoka A, Hasegawa M (2012) Epitope mapping of antibodies against TDP-43 and detection of protease-resistant fragments of pathological TDP-43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Biochem Biophys Res Commun 417:116\u2013121. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2011.11.066","journal-title":"Biochem Biophys Res Commun"},{"key":"755_CR41","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/ene.12675","volume":"22","author":"JL Whitwell","year":"2015","unstructured":"Whitwell JL, Boeve BF, Weigand SD, Senjem ML, Gunter JL, Baker MC, DeJesus-Hernandez M, Knopman DS, Wszolek ZK, Petersen RC et al (2015) Brain atrophy over time in genetic and sporadic frontotemporal dementia: a study of 198 serial magnetic resonance images. Eur J Neurol 22:745\u2013752. \n                    https:\/\/doi.org\/10.1111\/ene.12675","journal-title":"Eur J Neurol"},{"key":"755_CR42","doi-asserted-by":"publisher","first-page":"13302","DOI":"10.1074\/jbc.M800342200","volume":"283","author":"MJ Winton","year":"2008","unstructured":"Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, Lee VM (2008) Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J Biol Chem 283:13302\u201313309. \n                    https:\/\/doi.org\/10.1074\/jbc.M800342200","journal-title":"J Biol Chem"},{"key":"755_CR43","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0197-4580(97)00057-2","volume":"18","author":"Working Group","year":"1997","unstructured":"Working Group (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan institute working group on diagnostic criteria for the Neuropathological assessment of Alzheimer's disease. Neurobiol Aging 18:S1\u2013S2","journal-title":"Neurobiol Aging"},{"key":"755_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-015-1412-5","volume":"130","author":"S Xiao","year":"2015","unstructured":"Xiao S, Sanelli T, Chiang H, Sun Y, Chakrabartty A, Keith J, Rogaeva E, Zinman L, Robertson J (2015) Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death. Acta Neuropathol 130:49\u201361. \n                    https:\/\/doi.org\/10.1007\/s00401-015-1412-5","journal-title":"Acta Neuropathol"},{"key":"755_CR45","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1093\/hmg\/ddt166","volume":"22","author":"YJ Zhang","year":"2013","unstructured":"Zhang YJ, Caulfield T, Xu YF, Gendron TF, Hubbard J, Stetler C, Sasaguri H, Whitelaw EC, Cai S, Lee WC et al (2013) The dual functions of the extreme N-terminus of TDP-43 in regulating its biological activity and inclusion formation. Hum Mol Genet 22:3112\u20133122. \n                    https:\/\/doi.org\/10.1093\/hmg\/ddt166","journal-title":"Hum Mol Genet"},{"key":"755_CR46","doi-asserted-by":"publisher","first-page":"7607","DOI":"10.1073\/pnas.0900688106","volume":"106","author":"YJ Zhang","year":"2009","unstructured":"Zhang YJ, Xu YF, Cook C, Gendron TF, Roettges P, Link CD, Lin WL, Tong J, Castanedes-Casey M, Ash P et al (2009) Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci U S A 106:7607\u20137612","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0755-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-019-0755-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0755-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:07:51Z","timestamp":1593562071000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-019-0755-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["755"],"URL":"https:\/\/doi.org\/10.1186\/s40478-019-0755-x","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"assertion":[{"value":"17 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Mayo institutional Review Board (IRB) has deem this study exempt from IRB review and approval given that it utilizes postmortem brain tissue only.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}